公司资讯

Pason Chemicals

日期:2021-08-16 12:50:52 访问量:801 来源:北京派胜医药科技有限公司

Pason has been focusing on the research and development of anti-HBV drugs. Currently, there are total of 3

new products in the development pipeline.


Chemical Drugs


BP-Inter 014 (I.V.)


It  is  a nucleotide  analogue,  which  inhibits  HBV-DNA  synthesis.  Both  in  vitro  and  in  vivo  experiments  have

demonstrated  that  the  drug  had  strong  anti-HBV  function.



Herbal Medicine



BP-HM 002



The mixture of the extractions from 6 natural Chinese herbs.

The pre-clinical experiments have shown that this traditional medicine had strong anti-HBV effects.



BP-HM 36


The extraction from a wild herb on the high mountains in North-west of China.

The pre-clinical research suggested that the medicine could stimulate the recovery and the growth of bone


marrow cells after the chemical therapies.